Bai‐Cheng He

5.6k total citations
86 papers, 2.0k citations indexed

About

Bai‐Cheng He is a scholar working on Molecular Biology, Rheumatology and Cancer Research. According to data from OpenAlex, Bai‐Cheng He has authored 86 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 12 papers in Rheumatology and 12 papers in Cancer Research. Recurrent topics in Bai‐Cheng He's work include TGF-β signaling in diseases (26 papers), Bone Metabolism and Diseases (16 papers) and Bone and Dental Protein Studies (9 papers). Bai‐Cheng He is often cited by papers focused on TGF-β signaling in diseases (26 papers), Bone Metabolism and Diseases (16 papers) and Bone and Dental Protein Studies (9 papers). Bai‐Cheng He collaborates with scholars based in China, United States and Thailand. Bai‐Cheng He's co-authors include Ke Wu, Tong‐Chuan He, Zhong‐Liang Deng, Jinyong Luo, Wen‐Juan Sun, Liangjun Yin, Guowei Zuo, Beizhong Liu, Jiahui Zhu and Ranxi Zhang and has published in prestigious journals such as PLoS ONE, Biomaterials and Biochemical and Biophysical Research Communications.

In The Last Decade

Bai‐Cheng He

85 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bai‐Cheng He China 29 1.3k 323 205 200 180 86 2.0k
Don‐Kyu Kim South Korea 26 1.3k 1.0× 193 0.6× 255 1.2× 184 0.9× 113 0.6× 69 2.5k
Myoung Ok Kim South Korea 25 1.1k 0.8× 211 0.7× 202 1.0× 94 0.5× 130 0.7× 106 1.9k
Xiong Zhang China 27 1.3k 1.0× 443 1.4× 205 1.0× 174 0.9× 72 0.4× 109 2.4k
Seong Min Kim South Korea 20 857 0.7× 153 0.5× 139 0.7× 162 0.8× 95 0.5× 64 2.0k
Pengfei Hu China 26 845 0.7× 319 1.0× 186 0.9× 323 1.6× 95 0.5× 69 2.0k
Jiumao Lin China 22 703 0.6× 214 0.7× 247 1.2× 189 0.9× 171 0.9× 87 1.5k
Ting Zhao China 26 865 0.7× 231 0.7× 239 1.2× 86 0.4× 83 0.5× 141 2.2k

Countries citing papers authored by Bai‐Cheng He

Since Specialization
Citations

This map shows the geographic impact of Bai‐Cheng He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bai‐Cheng He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bai‐Cheng He more than expected).

Fields of papers citing papers by Bai‐Cheng He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bai‐Cheng He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bai‐Cheng He. The network helps show where Bai‐Cheng He may publish in the future.

Co-authorship network of co-authors of Bai‐Cheng He

This figure shows the co-authorship network connecting the top 25 collaborators of Bai‐Cheng He. A scholar is included among the top collaborators of Bai‐Cheng He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bai‐Cheng He. Bai‐Cheng He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Lu, Yue Jiang, Wenting Liu, et al.. (2025). SIRT5 promotes the osteo-inductive potential of BMP9 by stabilizing the HIF-1α protein in mouse embryonic fibroblasts. Genes & Diseases. 12(4). 101563–101563. 1 indexed citations
2.
3.
Jiang, Yue, et al.. (2023). MMP13 promotes the osteogenic potential of BMP9 by enhancing Wnt/β-catenin signaling via HIF-1α upregulation in mouse embryonic fibroblasts. The International Journal of Biochemistry & Cell Biology. 164. 106476–106476. 5 indexed citations
4.
Liu, Siyuan, Yuanyuan Yang, Xintong Yao, et al.. (2023). Matricellular Protein SMOC2 Potentiates BMP9-Induced Osteogenic Differentiation in Mesenchymal Stem Cells through the Enhancement of FAK/PI3K/AKT Signaling. Stem Cells International. 2023. 1–21. 3 indexed citations
5.
Yang, Yuanyuan, et al.. (2023). lncRNA MEG3 Promotes PDK4/GSK-3β/β-Catenin Axis in MEFs by Targeting miR-532-5p. Oxidative Medicine and Cellular Longevity. 2023. 1–27. 3 indexed citations
6.
Yao, Xintong, et al.. (2022). Resveratrol inhibits proliferation and induces apoptosis via the Hippo/YAP pathway in human colon cancer cells. Biochemical and Biophysical Research Communications. 636(Pt 1). 197–204. 21 indexed citations
7.
Yang, Yuanyuan, et al.. (2022). Analysis and Validation of Hub Genes in Blood Monocytes of Postmenopausal Osteoporosis Patients. Frontiers in Endocrinology. 12. 815245–815245. 24 indexed citations
8.
Wang, Feng, Kai Hou, Wenjing Chen, et al.. (2019). Transgenic PDGF-BB/sericin hydrogel supports for cell proliferation and osteogenic differentiation. Biomaterials Science. 8(2). 657–672. 31 indexed citations
9.
Li, Yang, Ying Shao, Wenyan Ren, et al.. (2017). Resveratrol inactivates PI3K/Akt signaling through upregulating BMP7 in human colon cancer cells. Oncology Reports. 38(1). 456–464. 47 indexed citations
10.
Li, Yang, Ying Shao, Wenyan Ren, et al.. (2017). TGF-β1/PTEN/PI3K signaling plays a critical role in the anti-proliferation effect of tetrandrine in human colon cancer cells. International Journal of Oncology. 50(3). 1011–1021. 19 indexed citations
11.
Zou, Xiang, et al.. (2016). Follicle‐Stimulating Hormone β‐Subunit Potentiates Bone Morphogenetic Protein 9‐Induced Osteogenic Differentiation in Mouse Embryonic Fibroblasts. Journal of Cellular Biochemistry. 118(7). 1792–1802. 16 indexed citations
12.
Chen, Zhenhua, et al.. (2016). Correlation of PI3K / Akt signaling pathway with anti-proliferative effect of evodiamine in colon cancer cells. Di-Si Junyi Daxue xuebao. 492–495. 1 indexed citations
13.
Yu, Yu, et al.. (2016). Oridonin upregulates PTEN through activating p38 MAPK and inhibits proliferation in human colon cancer cells. Oncology Reports. 35(6). 3341–3348. 30 indexed citations
14.
Xu, Lu, et al.. (2015). Bexarotene Reduces Blood-Brain Barrier Permeability in Cerebral Ischemia-Reperfusion Injured Rats. PLoS ONE. 10(4). e0122744–e0122744. 27 indexed citations
15.
Meng, Zijun, Yang Liu, Zou Xiang, et al.. (2015). Evodiamine inhibits the proliferation of human osteosarcoma cells by blocking PI3K/Akt signaling. Oncology Reports. 34(3). 1388–1396. 44 indexed citations
16.
Wang, Jinhua, Yingzi Liu, Liangjun Yin, et al.. (2013). BMP9 and COX-2 form an important regulatory loop in BMP9-induced osteogenic differentiation of mesenchymal stem cells. Bone. 57(1). 311–321. 55 indexed citations
17.
Gao, Jian‐Li, Guiyuan Lv, Bai‐Cheng He, et al.. (2013). Ginseng saponin metabolite 20(S)-protopanaxadiol inhibits tumor growth by targeting multiple cancer signaling pathways. Oncology Reports. 30(1). 292–298. 74 indexed citations
18.
Wang, Yang, Ningning Wu, Min Hu, et al.. (2012). Inhibitory Effect of Adenovirus-Mediated siRNA-Targeting BMPR-IB on UHMWPE-Induced Bone Destruction in the Murine Air Pouch Model. Connective Tissue Research. 53(6). 528–534. 5 indexed citations
19.
He, Bai‐Cheng. (2011). Effect of ATRA on the growth of 143B osteosarcoma cells. Zhongguo yaolixue tongbao. 1 indexed citations
20.
He, Bai‐Cheng. (2006). Experimental Study on Neurodegeneration Induced by Aluminum Overload in Mice. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026